terminology and guidelines for glaucoma ii - Kwaliteitskoepel

More documents

Recommendations

Info

$Refractiechirurgie - Nederlands Oogheelkundig Gezelschap$

References 1) Bengtsson B, Heijl A, Olsson J. Evaluation of a new hreshold visual field strategy, SITA, in normal subjects. Acta Ophthalmol Scand 1998;76:165-169. 2) Sample PA, Taylor JDN, Martinez GA, Lusky M, Weinreb RN. Short-wave lenght colour visual field in glaucoma suspect at risk. Am J Ophthalmol 1993;115:225-233. 3) Felius J, De Long LAS, Van de Berg TP, Greve EL. Functional characteristics of blue on yellow perimetric thres holds in glaucoma. Invest Ophthalmol Vis Sci 1995;36:1665-1674. 4) Frisèn L. High-Pass Resolution perimetry. Recent development. In Heijl A (eds). Perimetry update 1988/89. Berkeley-Milano, Kugler-Ghedini 1989,369-375. 5) Iester M, Alteri M, Vittone P, Calabria G, ZingirianM, Traverso CE. Detection of glaucomatous visual field defect by non-conventional perimetry. Am J Opthalmol 2003;135:35-39. 6) Johnson CA, Samuel SJ. Screening for glaucomatous visual field loss with frequency doubling perimetry. Invest OphthalmolVis Sci 1997;38:413-425. 7) Iester M, Mermoud A, Schnyder C. Frequency Doubling Technique in subject with ocular hypertension and glaucoma. Correlation with Octopus Perimeter Indices. Opthalmology 2001;107:228-294. 8) Wall M, Ketoff KM. Random dot motion perimetry in patients with glaucoma and in normal subjects. Am J Ophthalmol 1995;120:587-596. 9) Lachenmayer BJ, Drance SM, Chauhan BC, House PH, Lalani S. Diffuse and localized glaucomatous field loss in light-sense flicker and resolution perimetry. Graefe’s Arch Clin Exp Ophthalmol 1991;229:246-251. 10) Brusini P, Tosoni C. Staging of functional damage in glaucoma using frequency doubling techology. J Glaucoma (in press). 11) Heijl A, Bengtsson B. The effect of perimetric experience in patients with glaucoma. Arch Ophthalmol 1996;114:19-22. 12) Flammer J. The concept of visual field indices. Graefe’s Arch Clin Exp Ophthalmol 1986;224:389-392. 13) Bebie H, Flammer J, Bebie Th. The cumulative defect curve: separation of local and diffuse components of visual field damage. Graefe’s Arch Clin Exp Ophthalmol 1989;227:9-12. 14) Aasman P, Heijl A. Evaluation of methods for automated hemifield analysis in perimetry. Arch Ophthalmol 1992;110:812-819. 15) Katz J, Quigley HA, Sommer A. Detection of incident field loss using the glaucoma hemifield test. Ophthalmology 1996;103:657-663. 16) Brusini P. Stadiazione del difetto perimetrico nel glaucoma. Oftalmografia, 2, Ed. Innovation-News- Communication, Roma, 1996. 17) Hodapp E, Parrish IIRK, Anderson DR. Clinical decision in glaucoma. St Louis, CV Mosby Comp 1993;52-61. 18) Aulhorm E, Karmeyer H. Frequency distribution in early glaucomatous visual field defects. Doc Ophthalmol Proc Series 1977;14:75-83. 19) The Advanced Glaucoma Intervention Study Investigators: Advanced Glaucoma Intervention Study. Visual field test scoring and reliability. Ophthalmology 1994;101:1445-1455. 20) Langerhorst CT, van den Berg TJTP, Greve EL. Fluctuation and general health in automated perimetry in glaucoma. In Heijl A (eds). Perimetry update 1988/89. Berkeley-Milano, Kugler-Ghedini 1989,159-164. 21) Estermann B. Grid for scoring visual fields. II Perimeter. Arch Ophthalmol 1968;79:400-406. 22) Del Vecchio GC, Brombin A, Cavallini GM, Bussolari L. Metodo di calcolo per l’assegnazione di un punteggio al campo visivo computerizzato di soglia. Minerva Oftalmol 1998;40:95-101. 23) Gandolfo E, Zingirian M, Capris P. A new proposal for classification and quantification of visual field disability. In: Mills RP, Heijl A (eds). Perimetry update 1990-91, Amsterdam, New York, Kugler publ, 1991;545-549. 24) Gollamudi S, Liao P, Hirsch J. Evaluation of corrected loss variance as a visual field index. Corrected loss variance in conjunction with mean defect may identify stages of glaucoma. Ophthalmologica 1988;197:144-150. 25) Brusini P. Clinical use of a new method for visual field damage classification in glaucoma. Eur J Ophthalmol 1996;6:402-407. 26) Kocak I, Zulauf M, Hendrickson P, Stumpfig D. Evaluation of the Brusini glaucoma staging system for followup in glaucoma. Eur J Ophthalmol 1997;7:345-350. 27) Shin YS, Suzumura H, Furuno, Harasawa K, Endo N, Matsuo H. Classification of glaucomatous visual field defect using the Humphrey field analizer Box-plots. In: Mills RP, Heel A (eds) Perimetry Update 1990-91, Amsterdam, New York, Kugler, 1991;235-243. Ch. 1 - 31 EGS
28) Mc Naught AI, Crabb DP, Fitzke FW, Hitchings RA. Visual field progression: comparison of Humphrey Statpac 2 and point-wise linear regression analysis. Graefe’s Arch Clin Exp Ophthalmol 1996;243:411-418. 29) Birch MK, Wishart PK, O’Donnell NP. Determining progressive visual field loss in serial Humphrey visual fields. Ophthalmology 1995;102:1227-1235. 30) Fitzke FW, Hitchings RA, Poinoosawmy D, Mc Naught AI, Crabb DP. Analysis of visual field progression in glaucoma. Br J Ophthalmol 1996;80:40-46. 31) Hodapp E, Parrish IIRK, Anderson DR. Clinical decisions in glaucoma. St Louis, The CV Mosby, 1993;84-126. Ch. 1 - 32 EGS
Page 2 and 3:
ISBN: 88-87434-13-1 Editrice DOGMA
Page 4 and 5:
ACKNOWLEDGEMENT This work was made
Page 6 and 7:
2.2.5 - Primary Open-Angle Glaucoma
Page 8 and 9:
Foreword These Definitions and Guid
Page 10 and 11:
INTRODUCTION The aim of the book is
Page 12 and 13:
Since resources are limited worldwi
Page 14 and 15:
II - RANDOMIZED CONTROLLED TRIALS F
Page 16 and 17: II.3 - COLLABORATIVE NORMAL TENSION
Page 18 and 19: No stratification for stage of dise
Page 20 and 21: II. 6. 3 - from CNTG 1. Therapy tha
Page 22 and 23: References 1) The Ocular Hypertensi
Page 24 and 25: I - QUESTIONS TO ASK TO YOUR GLAUCO
Page 26 and 27: III - ABNORMAL THRESHOLD VISUAL FIE
Page 28 and 29: V - GONIOSCOPIC OPEN ANGLES SOME DI
Page 30 and 31: VII - TREATMENT STEPLADDER JUVENILE
Page 32 and 33: IX - MONOTHERAPY (in alphabetic ord
Page 34 and 35: XI - MANAGEMENT ACUTE ANGLE CLOSURE
Page 36 and 37: XIII - ANTIMETABOLITES FOR WOUND MO
Page 38 and 39: CHAPTER 1 PATIENT EXAMINATION
Page 40 and 41: Other methods 22-25 : Air-puff tono
Page 42 and 43: References 1) Martin XD. Normal int
Page 44 and 45: 1.2 - GONIOSCOPY Gonioscopy is a fu
Page 46 and 47: 1 2 3 4 Fig. 1 Dynamic indentation
Page 48 and 49: The Spaeth classification Insertion
Page 50 and 51: References 1) Palmberg P. Gonioscop
Page 52 and 53: small - size mid - size large - siz
Page 54 and 55: Fig. 5 A) Cirumlinear vessel, B) Ba
Page 56 and 57: 1.3.4.3 - OCT The Optical Coherence
Page 58 and 59: 31) Carpineto P, Ciancaglini M, Zup
Page 60 and 61: central 24 or 30 central degrees re
Page 62 and 63: A retinal sensitivity value worse t
Page 64 and 65: HODAPP CLASSIFICATION 31 EARLY GLAU
Page 68 and 69: 1.5 - BLOOD FLOW 1.5.1 - VASCULAR F
Page 70 and 71: 28) Flammer J, Orgul S, Costa VP, O
Page 72 and 73: All forms of glaucoma should be cla
Page 74 and 75: 2.2 - PRIMARY OPEN-ANGLE GLAUCOMAS
Page 76 and 77: 2.2.4 - PRIMARY OPEN-ANGLE GLAUCOMA
Page 78 and 79: 2.3 - SECONDARY OPEN-ANGLE GLAUCOMA
Page 80 and 81: 2.3.1.6 - Glaucoma due to intraocul
Page 82 and 83: 2.4 - PRIMARY ANGLE-CLOSURE Primary
Page 84 and 85: Systemic Risk factors for primary a
Page 86 and 87: OCCLUDABLE ANGLE: “Occludable”
Page 88 and 89: 2.5.3 - SECONDARY ANGLE-CLOSURE GLA
Page 90 and 91: CHAPTER 3 TREATMENT PRINCIPLES and
Page 92 and 93: Furthermore, blindness may occur de
Page 94 and 95: T A R G E T I O P Target IOP range
Page 96 and 97: Practical points for topical medica
Page 98 and 99: 3.3.1.1 - Category: ADRENERGIC AGON
Page 100 and 101: 3.3.1.2 - Category: ADRENERGIC ANTA
Page 102 and 103: 3.3.1.3 - Category: CARBONIC ANHYDR
Page 104 and 105: 3.3.1.4 - Category: PARASYMPATHOMIM
Page 106 and 107: 3.3.1.5 - Category: PROSTAGLANDIN D
Page 108 and 109: Drug interactions Precipitation occ
Page 110 and 111: COMBINATION THERAPY Starting* Addit
Page 112 and 113: 3.3.2.2 - Category: ADRENERGIC ANTA
Page 114 and 115: Pregnancy and nursing mothers Only
Page 116 and 117:
3.5 - LASER SURGERY 3.5.1 - LASER I
Page 118 and 119:
3.5.2 - LASER TRABECULOPLASTY 77-89
Page 120 and 121:
3.5.4 - CYCLOPHOTOCOAGULATION Indic
Page 122 and 123:
Although medical therapy is still t
Page 124 and 125:
3.6.4 - COMPLEX CASES Complicated g
Page 126 and 127:
Post-operative use Concentration: 0
Page 128 and 129:
25) Janz NK, Wren PA, Lichter PR, M
Page 130 and 131:
(Rescula TM ) in patients with glau
Page 132 and 133:
in white patients with open-angle g
Page 134 and 135:
CHAPTER 4 TREATMENT GUIDELINES
Page 136 and 137:
4.2 - PRIMARY OPEN-ANGLE GLAUCOMAS
Page 138 and 139:
4.2.7 - OCULAR HYPERTENSION (OH) Al
Page 140 and 141:
4.3.1.7 - Glaucoma associated with
Page 142 and 143:
• Withdrawal of aqueous from vitr
Page 144 and 145:
4.5 - SECONDARY ANGLE-CLOSURE GLAUC
Page 146 and 147:
4.5.3 - SECONDARY ANGLE-CLOSURE GLA
Page 148 and 149:
NOTES
Page 150 and 151:
NOTES
Page 152:
NOTES
show all

terminology and guidelines for glaucoma ii - Kwaliteitskoepel

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?